Tuan Ha-ngoc

Biography

 In June 2015, he was appointed executive chairman of KEW, Inc. a molecular profiling company utilizing Next Generation Sequencing technology with a mission of bringing Precision Medicine to All. From January to November 2015, Mr. Ha-Ngoc was the chairman of the Board of AVEO Pharmaceuticals, Inc., a company dedicated in the discovery and development of novel cancer medicines, having been its president and CEO since the beginning in 2002. From 1999 to 2002, he was co-founder, president and chief executive officer of deNovis, Inc., an enterprise-scale software development company for the automation of healthcare administrative functions. From 1998 to 1999, Mr. Ha-Ngoc was corporate vice president of strategic development for Wyeth, following Wyeth’s acquisition of Genetics Institute, where Mr. Ha-Ngoc served from 1984 to 1997 as executive vice president with responsibility for corporate development, commercial operations and European and Japanese operations. From 1976 to 1984, he served in various management capacities with Baxter Health Care first at their European headquarters then at their corporate offices in Deerfield, IL. He holds an M.B.A. from INSEAD and an M.A. in pharmacy from the University of Paris, France.

Research Interest

 Tuan Ha-Ngoc has more than 30 years of senior leadership experience in the biotech industry.